- Market Capitalization, $K 1,717,957
- Shares Outstanding, K 114,760
- Annual Sales, $ 46,550 K
- Annual Income, $ -75,240 K
- 60-Month Beta 1.37
- Price/Sales 36.71
- Price/Cash Flow N/A
- Price/Book 24.33
|Period||Period Low||Period High||Performance|
| || |
+2.93 (+24.34%)since 08/20/21
| || |
+6.04 (+67.64%)since 06/18/21
| || |
+9.54 (+175.69%)since 09/18/20
Investors in Dynavax Technologies Corp saw new options become available this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX...
Stocks Finally Have a Solid Session in September
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Morning Markets Dec S&P 500 futures this morning are up +0.57% as they recover more than half of Friday’s decline. Strength in energy and technology stocks in pre-market trading is supportive for the...
/PRNewswire/ -- (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that has received a termination notice from the United Kingdom Government...
/PRNewswire/ -- (Nasdaq: DVAX) today reported that it has granted nonstatutory stock options to purchase an aggregate of 224,000 shares of Dynavax common stock as inducements to 8 newly-hired employees...
Dynavax (DVAX) stock gains as partner Medigen announces launch of its COVID-19 vaccine MVC-COV1901 adjuvanted with CpG 1018 of the former.
NASDAQ Jumps Over 2.5% in 2 Days to Close at Record High
and , /PRNewswire/ -- (MVC) (TPEx: 6547.TWO), a biopharmaceutical company focusing on the development and production of vaccines and biologics, and (Nasdaq: DVAX), a biopharmaceutical company focused...
|Innovator Ibd 50 Fund ETF|
|Dynamic Biotechnology & Genome Invesco ETF|
|S&P Biotech SPDR|
|Etfmg Treatments Testing and Advancements ETF|
|Bioshares Biotech Clinical Trial|
|3rd Resistance Point||16.21|
|2nd Resistance Point||15.69|
|1st Resistance Point||15.33|
|1st Support Level||14.45|
|2nd Support Level||13.93|
|3rd Support Level||13.57|